Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1976

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

Figure-1 (Image 01)
This appears to be a graph showing the Mean Plasma Concentrations of Dextro and Levoamphetamine in ngint units at different time intervals. The x-axis represents time in hours, while the y-axis represents concentration levels in ngint. The graph has three lines representing the concentration levels of Dextroamphetamine, Levoamphetamine, and another unidentified drug shown by 'S.' The text in the graph's legend also includes some misspelled names of the drugs.*
FDA Label Image

Label (Lbl636291976)

Label (Lbl636291976)
This is a description of a medication called NILD, in the form of extended-release capsules, which contain various types of amphetamines. The text presents information about the dosage and storage of the medicine, as well as a recommendation to keep it away from children. The medication is to be dispensed in a container that meets the USP requirements and has a child-resistant closure.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.